ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACST Acasti Pharma Inc

2.8501
0.00 (0.00%)
Pre Market
Last Updated: 06:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Acasti Pharma Inc ACST NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 2.8501 06:00:00
Open Price Low Price High Price Close Price Previous Close
2.8501
more quote information »

Recent News

Date Time Source Heading
2/12/202407:00EDGAR2Form 8-K - Current report
2/12/202406:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
1/08/202407:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/08/202406:30EDGAR2Form 8-K - Current report
12/20/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202306:30EDGAR2Form 8-K - Current report
11/13/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/23/202315:30EDGAR2Form 8-K - Current report
10/16/202315:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/11/202315:30EDGAR2Form 8-K - Current report
10/06/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
9/27/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/26/202307:10EDGAR2Form 8-K - Current report
9/05/202314:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202316:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/25/202315:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/25/202315:15EDGAR2Form DEF 14A - Other definitive proxy statements
8/11/202306:31EDGAR2Form 8-K - Current report
8/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/24/202316:30EDGAR2Form 8-K - Current report
7/18/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202308:00PRNUSAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON..
7/07/202307:30EDGAR2Form 8-K - Current report
7/07/202307:00PRNUSAcasti Pharma Announces 1-for-6 Reverse Stock Split
7/05/202315:00EDGAR2Form 8-K - Current report
7/05/202308:00PRNUSAcasti Announces Alignment with FDA on GTX-104 Pivotal Phase..
6/23/202306:00PRNUSAcasti Pharma Reports Fiscal Year 2023 Operational Results
6/22/202308:00PRNUSAcasti Announces Appointment of New Scientific Advisory..
5/17/202308:00PRNUSAcasti to Participate in the Lytham Partners Spring 2023..
5/08/202306:00PRNUSAcasti Successfully Submits Pivotal GTX-104 Phase 3 Safety..

Your Recent History

Delayed Upgrade Clock